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Abstract The fusogenic subdomain of the Ebola virus envelope
glycoprotein is an internal sequence located ca. 20 residues
downstream the N-terminus of the glycoprotein transmembrane
subunit. Partitioning of the Ebola fusion peptide into mem-
branes containing phosphatidylinositol in the absence of Ca2+
stabilizes an K-helical conformation, and gives rise to vesicle
e¥ux but not vesicle fusion. In the presence of millimolar
Ca2+ the membrane-bound peptide adopts an extended L-struc-
ture, and induces inter-vesicle mixing of lipids. The peptide con-
formational polymorphism may be related to the £exibility of
the virus^cell intermembrane fusogenic complex.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ebola virions are surrounded by a lipidic envelope contain-
ing a single type of a highly glycosylated protein (Ebola GP)
that makes up the spikes protruding from the virion surface
[1^5]. Several ¢ndings con¢rm that structural Ebola GP is
responsible for receptor binding and membrane fusion during
Ebola entry into the host cells [6^8]. Ebola GP is synthesized
as a precursor molecule and subsequently cleaved by furin
into two disul¢de-linked subunits, surface (GP1) and trans-
membrane (GP2) that, similarly to other viral envelope glyco-
proteins, are arranged as trimers of heterodimers [4,5].
Gallaher [9] predicted the existence in GP2 of an internal
fusion peptide of approximately 16 uncharged, hydrophobic
residues. Subsequent experiments demonstrated that the se-
quence interacted with and fused lipid vesicles [10]. Partition-
ing of the peptide into bilayers required the presence of phos-
phatidylinositol that is conspicuously represented in the
plasma membrane of the hepatocyte, one important viral tar-
get for Ebola infection [1]. Mutational analysis provided addi-
tional evidence supporting the role of the GP2 fusion peptide
in the fusion process and viral infectivity [11].
In this contribution we have analyzed the energetics and
structural requirements for interaction with lipid vesicles of
EBOGE, a peptide representing the Ebola fusion region. The
structural characterization con¢rms that folding occurs in
membranes containing phosphatidylinositol. Furthermore we
observe that the peptide may exist in three di¡erent states,
namely unbound random coil, membrane-bound K-helix, or
membrane-bound L-strand. The adoption of an K-helical
structure in the absence of Ca2þ appears to be related to
the ability of the peptide to perturb membranes and cause
permeabilization, whereas the L-structure is observed in the
presence of Ca2þ under conditions leading to fusion. Thus,
our data are consistent with the existence of structurally poly-
morphic states of membrane-bound Ebola internal fusion pep-
tide. These ¢ndings provide information on the properties of
the cell^virus intermembrane fusion complex.
2. Materials and methods
Phosphatidylcholine (PC), phosphatidylinositol (PI), and the £uo-
rescent probes N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl)phosphatidyle-
thanolamine (N-NBD-PE) and N-(lissamine rhodamine B sulfonyl)-
phosphatidylethanolamine (N-Rho-PE) were purchased from Avanti
Polar Lipids (Birmingham, AL, USA). 8-Aminonaphtalene-1,3,6-tri-
sulfonic acid sodium salt (ANTS) and p-xylenebis(pyridinium)bro-
mide (DPX) were from Molecular Probes (Junction City, OR,
USA). D2O, tri£uoroethanol (TFE), N-acetyl-L-tryptophanamide
(NATA) and Triton X-100 were obtained from Sigma (St. Louis,
MO, USA). The sequence representing the putative fusogenic segment
of Ebola GP, GAAIGLAWIPYFGPAAE, EBOGE, was synthesized
as its C-terminal carboxamide and puri¢ed (estimated homogeneity
s 90%) by Quality Controlled Biochemicals, Inc. (Hopkinton, MA,
USA). Peptide stock solutions were prepared in dimethylsulfoxide
(DMSO) (spectroscopy grade).
Vesicles were prepared according to two di¡erent protocols. For the
preparation of small unilamellar vesicles (SUV) dried lipid ¢lms were
dispersed in bu¡er, 5 mM HEPES, 100 mM NaCl (pH 7.4) and
sonicated with a probe sonicator. Large unilamellar vesicles (LUV)
were prepared following the extrusion method of Hope et al. [12] in
5 mM HEPES, 100 mM NaCl (pH 7.4) bu¡er. Lipid concentrations
of liposome suspensions were determined by phosphate analysis [13].
Leakage and membrane-mixing measurements were conducted at
37‡C in thermostatically controlled cuvettes using a Perkin-Elmer
LS50-B spectro£uorometer. The medium in the cuvettes was contin-
uously stirred to allow the rapid mixing of peptide and vesicles. Re-
lease of vesicular contents to the medium was monitored by the
ANTS/DPX assay. LUV containing 12.5 mM ANTS, 45 mM DPX,
20 mM NaCl and 5 mM HEPES [14] were obtained by separating the
unencapsulated material by gel ¢ltration in a Sephadex G-75 column
eluted with 5 mM HEPES, 100 mM NaCl (pH 7.4). Osmolarities were
adjusted to 200 mosm in a cryoscopic osmometer (Osmomat 030,
Gonotec, Berlin, Germany). Fluorescence measurements were per-
formed by setting the ANTS emission at 520 nm and the excitation
at 355 nm. A cuto¡ ¢lter (470 nm) was placed between the sample and
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the emission monochromator. The 0% leakage corresponded to the
£uorescence of the vesicles at time zero; 100% leakage was the £uo-
rescence value obtained after addition of Triton X-100 (0.5% v/v).
Final extent values of leakage were obtained at times at which the
kinetics of the process leveled o¡. Membrane lipid mixing was moni-
tored using the resonance energy transfer (RET) assay, described by
Struck et al. [15]. The assay is based on the dilution of N-NBD-PE
and N-Rho-PE. Dilution due to membrane mixing results in an in-
crease in N-NBD-PE £uorescence. Vesicles containing 0.6 mol% of
each probe were mixed with unlabeled vesicles at 1:4 ratio. The NBD
emission was monitored at 530 nm with the excitation wavelength set
at 465 nm. A cuto¡ ¢lter at 515 nm was used between the sample and
the emission monochromator to avoid scattering interferences. The
£uorescence scale was calibrated such that the zero level corresponded
to the initial residual £uorescence of the labeled vesicles and the 100%
value to complete mixing of all the lipids in the system. The latter
value was set by the £uorescence intensity of vesicles, labeled with
0.12 mol% each of the £uorophores, at the same total lipid concen-
tration as in the fusion assay.
Partitioning isotherms were performed by monitoring the fractional
change in emitted Trp £uorescence of EBOGE titrated with increasing
lipid concentrations. Fluorescence was recorded in a Perkin-Elmer
MPF-66 spectro£uorometer with excitation and emission monochro-
mators set at 280 and 348 nm respectively and the corresponding slits
at 2.5 and 10 nm. The signal was further corrected for dilution and
inner ¢lter e¡ects as described in [16] using the soluble Trp analog
NATA unable to partition into membranes.
Circular dichroism (CD) measurements were carried out on a Jobin
Yvon CD6 circular dichroism spectropolarimeter (CD-Longjumeau,
France) calibrated routinely with isoandrosterone. The spectra were
measured in a 1 mm path-length quartz cell. Data were taken with a
0.2 nm step size, 8 s average time, 20 nm/min speed, and the results of
10 scans were averaged. CD spectra were taken at 25‡C, in 5 mM
MOPS bu¡er, pH 7 in the presence of 100 mM NaCl. Peptide con-
centration was 40 WM as determined by ultraviolet (UV) spectroscopy
using O280 = 7050 M31 cm31 from the contribution to the UV spec-
trum of tryptophan and tyrosine [17].
Infrared spectroscopy (IR) measurements were essentially con-
ducted as in [18]. Samples in presence of vesicles consisted of £oated
peptide^lipid complexes obtained in D2O bu¡er after ultracentrifuga-
tion. Solvent samples were also obtained from the supernatant frac-
tion not containing lipid or peptide and subsequently used as back-
ground controls. Infrared spectra were recorded in a Nicolet 520
spectrometer equipped with an MCT detector. Samples were placed
between two CaF2 windows separated by 50 Wm spacers. 500 scans
(sample) and 500 scans (reference) were taken for each spectrum,
using a shuttle device. Spectra were transferred to a personal com-
puter where solvent subtraction and band position determinations
were performed as previously reported [19]. Curve-¢tting of the orig-
inal amide I band was carried out with the GRAMS software (Galac-
tic Corp.). The area under each peak was used to calculate the per-
centage of each component and ¢nally to estimate the percentage of
secondary structure components. The estimated errors are V 1 cm31
for the band position and V 5% for the peak area [19].
3. Results
It has been reported [10] that inclusion of anionic PI in the
bilayer composition promoted binding of EBOGE to vesicles.
In addition, calcium was necessary to observe EBOGE-medi-
ated fusion of vesicles. Results in Fig. 1 demonstrate that
EBOGE-induced permeabilization and fusion of PI membranes
appear to be mutually exclusive processes and that calcium
governs which of the two will prevail in a given situation.
Peptide addition to a suspension of PI vesicles in the absence
of Ca2þ induced extensive e¥ux of aqueous contents to the
medium (Fig. 1A, curve a). However, the ongoing leakage
process could be arrested by addition of calcium (curve b).
Moreover, when the cation was present in the PI vesicle sam-
ple bu¡er, peptide addition induced negligible leakage (curve
c). Fig. 1B shows the in£uence of Ca2þ concentration on pep-
tide-induced leakage. 50% inhibition was observed for ca. 0.1
mM calcium concentration, and inhibition (ca. 90%) was max-
imum above 1.0 mM. Leakage inhibition correlated with pro-
motion by the cation of peptide-induced inter-vesicle mixing
of lipids (Fig. 1C). Thus calcium modulated two dissimilar
Fig. 1. EBOGE peptide-induced leakage of contents (ANTS/DPX as-
say) and fusion (membrane lipid mixing, RET assay) of PI LUV.
A: Kinetics of leakage and e¡ect of calcium addition. (a) Control
assay in absence of the cation, the peptide was added at the time in-
dicated by arrow ‘1’; (b) the cation was added after the onset of
the process at the time indicated by arrow ‘2’; (c) the cation was
present before the addition of the peptide. The peptide was added
at the peptide to lipid mole ratio of 1:5 and ¢nal calcium concen-
tration was 5 mM. B: E¡ect of increasing calcium concentrations
on the ¢nal extents of EBOGE-induced leakage (added peptide to
lipid mole ratio of 1:5). C: Mixing of lipids as a function of time.
(a) and (b) As in the previous panel. Lipid concentration was 100
WM in all cases.
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vesicle perturbing e¡ects of the peptide. In what follows addi-
tional evidence will be provided indicating that these processes
were promoted by the same amount of membrane-bound pep-
tide. However, the structures adopted by the peptide in the
membrane were di¡erent.
The water^membrane peptide partition equilibrium was
next characterized under conditions allowing each of the
two mutually exclusive processes to evolve (Fig. 2). Associa-
tion of EBOGE to PC:PI (1:2 mole ratio) SUV in the absence
of Ca2þ had been previously evaluated at a ¢xed lipid con-
centration by physically separating solution-free and lipid-
bound fractions by centrifugation (table 2 in [10]). In addi-
tion, the amount of lipid-bound peptide was estimated in the
same intact system using a resonance energy transfer assay.
Here, this partition equilibrium was further characterized by
constructing the partition isotherm [16]. Self-aggregation in
solution due to its hydrophobic character may interfere with
peptide incorporation into target membranes, a fact that
precludes the experimental characterization of the water^
membrane peptide partitioning equilibrium. In a control ex-
periment, it was shown by CD spectroscopy that, in the
micromolar concentration range used to measure partitioning,
EBOGE remained unfolded and non-aggregated for hours in
solution. Thus, peptide self-aggregation that might interfere
with peptide incorporation into target membranes could be
obviated as a source of error under our experimental condi-
tions.
The partition coe⁄cient was evaluated by monitoring the
increase of the Trp £uorescence emission intensity when lipid
vesicles were added to EBOGE. The apparent mole fraction
partition coe⁄cients, Kx, were determined by ¢tting the ex-
perimental values (circles in Fig. 2) to a hyperbolic function.
From the corresponding curve an apparent partition coe⁄-
cient KxV2.6U105 was computed. Similar values for this pa-
rameter (0.5U105 and 1.1U105) had been obtained using dif-
ferent methods, at a ¢xed lipid concentration of 0.5 mM [10].
Results in Fig. 2 also demonstrate that the presence of calci-
um does not a¡ect the partition equilibrium (triangles). Thus,
the possibility that Ca2þ-triggered fusion (Fig. 1) was due to a
massive peptide binding to vesicles could be ruled out. Possi-
ble conformational changes that would explain the di¡erent
perturbing e¡ects of the peptide were next examined by spec-
troscopic techniques under various experimental conditions.
The conformation of the peptide in solution was ¢rst char-
acterized by CD spectroscopy. As mentioned above, the CD
spectrum in bu¡er solution (100 mM NaCl) indicated a ran-
dom coil conformation for the peptide (Fig. 3). This confor-
mation was independent of the ionic strength of the medium
as demonstrated by the lack of conformational change when
the peptide solution was titrated with NaCl up to a 1 M ¢nal
salt concentration. No signi¢cant changes were observed ei-
ther for the peptide in bu¡er solution in the presence of 1 mM
CaCl2. Consistent with these observations the AGADIR pro-
gram [20] predicts an extremely low helical content (6 5%) in
neat aqueous solution (data not shown).
A decrease in peptide environmental polarity occurs when
the peptide is transferred from water to membrane interfaces.
The e¡ect of polarity on peptide conformation can be studied
by using aqueous mixtures of methanol or TFE. In both
cases, the polarity of the medium decreases, however only
TFE can induce periodic secondary structure by promoting
intramolecular hydrogen bond formation [21^23]. Thus, in the
presence of 20% methanol the peptide remained in a random
coil conformation (not shown), while in the presence of 20%
TFE the CD spectrum of the peptide already showed a neg-
ative band at 222 nm (Fig. 3), suggesting the adoption of an
K-helical conformation. Increasing concentrations of TFE in-
duced a further helical stabilization (Fig. 3). In contrast, in the
presence of 60% methanol the peptide displayed a dominant
random coil conformation. The helical conformation induced
by TFE was independent of the salt content in the bu¡er,
indeed the TFE titration pro¢les in a bu¡er containing no
NaCl (not shown) were almost superimposable to those ob-
tained in the presence of 100 mM NaCl shown in Fig. 3. The
data altogether suggest that the peptide contains a particular
sequence of amino acids that, in a suitably non-polar environ-
ment, can adopt an K-helical conformation. We dismissed the
use of CD for characterizing the membrane-bound structures
of EBOGE because PI vesicles in the presence of Ca2þ readily
Fig. 2. Partitioning of EBOGE from water into membranes. Parti-
tioning was estimated from Trp £uorescence changes in the presence
of increasing concentrations of PC:PI (1:2, mole ratio) SUV in ab-
sence (b) or presence of 5 mM calcium (R). The soluble Trp ana-
log NATA was used to obtain a reference curve corresponding to
0% binding. Peptide concentration in all cases was 0.25 WM.
Fig. 3. Far UV CD spectra of EBOGE in the presence of increasing
TFE percentages. Spectra values are expressed as mean molar ellip-
ticity per residue. Peptide concentration was 40 WM.
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aggregated giving rise to cloudy dispersions. These samples
were not appropriate for CD measurements.
Light scattering e¡ects do not signi¢cantly distort the IR
spectrum. For evaluating peptide conformation in concen-
trated and aggregated lipid samples this represents a technical
advantage. Thus, IR assays were performed to determine the
conformation adopted by EBOGE not only in bu¡er and tri-
£uoroethanol but also in the presence of vesicles (Fig. 4 and
Table 1). In D2O bu¡er the IR spectra of EBOGE in the amide
I region (data not shown) revealed the presence of several
absorption bands (centered at 1639 cm31), characteristic of
unordered conformations while addition of TFE shifted the
absorption maximum to bands (centered at 1646 cm31), asso-
ciated with fully accessible K-helical conformations in deuter-
ated media [24]. Therefore, in good agreement with CD data,
IR described a mainly unordered to helical conformational
transition induced by TFE.
In the presence of lipid vesicles, the conformation of mem-
brane-bound peptide (isolated by £otation) was sensitive to
the experimental conditions (Fig. 4). In the absence of calcium
(Fig. 4A, see inset), exposure to the bilayer milieu promoted
folding of the sequence into a mainly K-helical secondary
structure characterized by an absorption maximum of the
amide I band at 1652 cm31. The data in Table 1 indicate
that membrane association in the absence of calcium increases
the K-helical content of the peptide. Assuming that the pro-
portion of K-helical conformation for the peptide in solution
is negligible, the percentage area estimated for the K-helical
component (43V 4%) would be consistent with V7 residues
changing from an unordered to an K-helical conformation.
Results in Fig. 1 show that the presence of calcium, added
either before or after the peptide, was necessary to observe
EBOGE-mediated fusion of vesicles. Neither the peptide alone
nor the cation on its own were capable of triggering the pro-
cess. The structural characterization revealed that this synergy
may be due to an e¡ect of calcium on the organization of the
membrane-associated peptide. IR data in Fig. 4 show that
addition of calcium to vesicles containing EBOGE induces a
structural transition from the K-helical conformation to a pre-
dominantly extended (L-type) structure. This conformational
rearrangement is evidenced by a shift of the amide I band
absorption maximum from 1652 cm31 (A) to 1622 cm31
(B), upon addition of calcium to the same lipid^peptide com-
plexes (Fig. 4, inset). This fact, together with the presence of
the high-frequency component at 1685 cm31 (see also Table
1), suggests that the peptide might adopt an extended anti-
parallel L-structure under these conditions [24].
4. Discussion
In most viral fusion events the hydrophobic fusion peptide,
usually located at the N-terminal end of the fusogenic subunit,
is thought to be involved in driving the initial partitioning of
the viral fusion protein into the target cell membrane [25], and
also to participate actively in the formation of a functional
fusion pore (for reviews see [25^28]). The mechanisms govern-
ing the direct interactions between these viral glycoprotein
fragments and the membrane lipids are thought to be essential
in understanding their fusogenic activity. N-terminal fusion
peptides, such as those derived from in£uenza or human im-
munode¢ciency virus fusion proteins, have been shown to
transfer spontaneously to membranes, to generate bilayer per-
turbations leading to permeabilization and fusion, and to be
conformationally polymorphic as membrane-associated spe-
cies, a phenomenon that has been related to their high content
of Gly and Ala residues [25^28]. Thus, unlike classical trans-
membrane anchors, fusion peptides inserted into target mem-
branes might adopt di¡erent conformations including helical
monomers penetrating in an oblique angle into one monolayer
[26,29,30], helical aggregates assembling transmembrane lytic
pores [31] and aggregates of extended strands producing local
dehydration and monolayer surface expansion [18,28,31^35].
Inter-conversion between the di¡erent conformational states
appears dictated by the peptide membrane surface density
[28,33], the lipid composition [18,31] and the monolayer lat-
eral pressure [36]. This conformational £exibility appears to
be functionally meaningful since mutations a¡ecting the fu-
sion capacity of the proteins have been shown to interfere
Table 1
Band components of IR spectra displayed in the inset of Fig. 4
Peak 3calcium (A) +10 mM calcium (B)
Center (cm31) Area (%) Center (cm31) Area (%)
1 1687 3V 1 1686 4V2
2 1671 28V 4 1670 24V3
3 1652 43V 4 1646 27V3
4 1638 5V 2 1626+1622 44V5
5 1623 21V 3
Fig. 4. IR spectra of EBOGE bound to PC:PI (1:2) vesicles. The
peptide (added peptide to lipid ratio, 1:17), was mixed with lipid
vesicles (1 mM) and peptide^lipid complexes were subsequently iso-
lated from the £oating fractions after ultracentrifugation in D2O
bu¡er. A represents the spectrum of a sample in absence of calcium.
B corresponds to an aliquot of sample A incubated with 10 mM
calcium for 30 min before being subjected to £otation. Spectra in
the inset were obtained after subtracting from the signal of peptide^
lipid samples (continuous curves) the one arising from pure lipid
samples treated similarly (dotted curves). Side-lobes in spectrum A
are due to small changes in the carbonyl lipid vibration at 1730
cm31 upon peptide partitioning.
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with the conformational state of the membrane-bound fusion
peptides [32,37^39].
In contrast to N-terminal fusion peptides, internal fusion
peptides are poorly characterized in their interactions with
membranes. Delos et al. [40,41] have approached the issue
of internal fusion peptides and their structure^function rela-
tionships. According to these authors, internal fusion peptides
are segmented following a common structural motif, namely
two ordered regions intervened by a turn or a loop, usually
containing one or more Pro residues. Maintenance of this
organization appears to be fundamental for the formation
of the native (metastable) fusion protein structure, as well as
for the membrane interactions that lead to fusion. In this
study we have characterized the ability of the internal fusion
peptide of Ebola glycoprotein to associate with membranes.
Our data reveal that, similarly to N-terminal fusion peptides,
internal Ebola fusion peptide perturbs bilayers inducing per-
meabilization and fusion, and that these processes appear
mediated by distinct conformations adopted in membranes.
However, in contrast to the former cases, we found e¡ective
incorporation of this internal sequence only when a particular
phospholipid, PI, was present in the membrane composition.
Partition of EBOGE into membranes may be discussed in
the context of current knowledge on interfacial partitioning
energetics [42,43]. Considering EBOGE as an electrically neu-
tral species, computation of the experimental free energy of
partitioning (vGexp =3RT ln Kx) gives an estimate of ca. 37.0
kcal mol31. Our IR data are consistent with the adoption by
approximately one-half of the EBOGE sequence (ca. seven to
eight residues) of a de¢ned secondary conformation upon en-
tering the membrane environment. Experimental evaluation
indicated that vGif , the per-residue free energy change upon
folding into membranes, is about 30.5 kcal mol31 [42,43].
Thus, the free energy change upon EBOGE folding into mem-
brane interfaces, vGif , would be in the range of 33.5 to 34.0
kcal mol31. We may conclude that spontaneous partitioning
of EBOGE into bilayers is greatly in£uenced by the ability of
the sequence to fold adopting a de¢ned secondary structure.
The important contribution of conformational energy prob-
ably explains why EBOGE did not partition in pure PC: the
peptide was incapable of adopting a de¢ned secondary struc-
ture in PC membranes. In addition, the peptide did not ex-
hibit any conformational change either when titrated with
mixed micelles of n-octyl-L-D-glucopyranoside or n-heptyl-L-
D-glucopyranoside and PI (data not shown). These ¢ndings
are consistent with the absence of stereospeci¢c interactions
of the peptide with inositol moieties that would promote in-
tramembrane folding of this sequence. Taking into account
that the acyl chain compositions of the PI and PC used in
this study were similar, it is tempting to speculate that EBOGE
partitioning into PI-containing membranes depends on a
structural role of the PI headgroup at the bilayer interface.
The intricate H-bonding network at the surface of PI-enriched
bilayers [44] may stabilize the unfolded partitioned peptide,
thus facilitating its transfer to less polar regions of the bilayer,
and its concomitant folding.
The present study shows that Ebola internal fusion peptide
may alternate conformations when bound to membranes. The
EBOGE sequence contains three Gly and ¢ve Ala residues,
which already suggests certain conformational £exibility.
The peptide was actually found to exist in two di¡erent struc-
tures in vesicles, one in the absence of calcium, that supports
ANTS/DPX leakage but inhibits fusion, and one in the pres-
ence of the cation in which the peptide supports mixing of
lipids and inhibits e¥ux (Fig. 1). In the absence of the cation
the peptide was predominantly found in an K-helix conforma-
tion, whereas in its presence the structure changed to a mainly
extended antiparallel L-structure (Fig. 4 and Table 1). Ca2þ at
millimolar concentrations will certainly bind the negatively
charged PI headgroups, with the result that PI-rich domains
in the target membrane will remain highly polar, but with
a smaller negative electric charge, and with a reorganized
H-bonding network. Those changes may well explain the dif-
ferent peptide secondary structures that are stabilized at the
membrane^water interface in the presence and absence of the
cation.
Thus, our structural characterization provides some insights
into the role of calcium as a co-promoter of fusion together
with the peptide. The cation-promoted L-type peptide struc-
ture, or a transient intermediate, appears to cause the sort of
membrane perturbations required for vesicle fusion. It is pos-
sible that the conformational polymorphism of the inserted
fusion peptide contributes to the £exibility of the fusogenic
complex by adapting to con¢gurations that can be either per-
pendicular or parallel to the target bilayer plane [45,46]. In
addition, membrane perturbations induced by peptides inter-
acting with the target membrane at the point of fusion might
promote distortion as proposed by Weissenhorn et al. [45].
During GP2-induced fusion, the target membrane perturba-
tion induced by the fusion peptide will be localized at the
point of fusion, and subsequently propagate into the closely
appositioned virion membrane.
Finally, we must caution here that our studies in model PI
membranes focus on unraveling the structural determinants
(in the fusion peptide and in the target bilayers) required to
sustain a perturbing interaction. An interaction that leads to a
general disorganization of the bilayer architecture is postu-
lated to evolve during membrane merger. How these require-
ments are provided in the context of the full glycoprotein
interacting with the endosomal membrane, where ¢lovirus^
cell fusion probably takes place, is at the present unknown.
In this regard, it is important to note that glycosylated forms
of PI might be quantitatively important in specialized lipid
domains of those membranes [47].
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